15 Amendments of Notis MARIAS related to 2016/2096(INI)
Amendment 16 #
Draft opinion
Paragraph 2
Paragraph 2
2. Calls on governments of developing countries to mainstream gender in mental health policy, and to develop policies and programmes that address both the specific needs of women for mental health treatment and the social origins of psychological distress; strongly believes that betterthe achievement of balance in gender roles and obligations, income security, equal access to education, the development of social safety nets and poverty reduction would further redress gender disparities in mental health;
Amendment 19 #
Motion for a resolution
Recital A
Recital A
A. whereas the right to health is a fundamental human right; and everyone should have free access to health care;
Amendment 22 #
Draft opinion
Paragraph 3
Paragraph 3
3. Stresses the need to invest in global health research, innovation and development (R&D) to strengthen national health systems by increasing EU spending in this sector and to achieve universal healthcare coverage; regretsdeplores the fact that the EU has not incorporated the principles of its global health policy into its innovation strategy; regrets alsodeplores the fact that there are no binding provisions in any of the mechanisms which ensure that Poverty- Related and Neglected Diseases (PRND) R&D funded through the EU will produce accessible, affordable, suitable and acceptable products for populations in resource-poor settings, or that research data will be openly accessible;
Amendment 27 #
Draft opinion
Paragraph 4
Paragraph 4
4. Notes with concernDeplores the fact that the increase in offshoring medicine testing to Africa mayis continuing to result in serious ethical violations; points out that not having access to affordable healthcare or health insurance gives vulnerable people, particularly women, no other choice than to participate in clinical trials in order to receive medical treatment;
Amendment 33 #
Draft opinion
Paragraph 5
Paragraph 5
5. Calls on transnational pharmaceutical companies to fulfil their corporate responsibility to respect human rights, as enshrined in the United Nations Guiding Principles on Business and Human Rights (UNGPBHR), whenand not to engaginge in clinical trials in low- and middle-income countries; deems that they should ensure the proper protection of participants’ safety and rights, and the conformity of their practices with the highest ethical standards.
Amendment 51 #
Motion for a resolution
Recital ΣΤ
Recital ΣΤ
F. whereas restrictions and budgetary cuts made by national governments in the area of public health also make access to health services more onerous; at the same time the violent fiscal adjustment imposed by the Troika does not allow southern European Member States, such as Greece, Spain, Portugal and Italy, to cope with the shortcomings of their health systems;
Amendment 67 #
Motion for a resolution
Recital I
Recital I
I. whereasdeploring the fact that only 10 EU Member States have set the very much- needed target of screening 100 % of the female population for breast cancer, and whereas only eight countries have such a target for cervical cancer screening;
Amendment 92 #
Motion for a resolution
Recital M
Recital M
M. whereas, because of a variety of factors, primarily concerning different gender roles and gender inequalities, and daily social discrimination, depression is approximately twice as prevalent among women as it is among men;
Amendment 103 #
Motion for a resolution
Recital O
Recital O
O. whereas male violence against women and its impacts on women’s health constitute a fundamental barrier to the achievement of gender equality and women’s full enjoyment of their human rights; and in some countries there has been a significant increase in the number of victims and the severity of the consequences of violence;
Amendment 110 #
Motion for a resolution
Recital P
Recital P
P. whereas women and girls who are subjected to female genital mutilation are exposed to serious short- and long-term effects on their physical, psychological, sexual and reproductive health;
Amendment 137 #
Motion for a resolution
Paragraph 1 – point b
Paragraph 1 – point b
(b) to recognise male violence against women as a public health issue, whatever form it takes, as it can cause physical and psychological harm;
Amendment 218 #
Motion for a resolution
Paragraph 7
Paragraph 7
7. Underlines the fact that screening procedures are considered to be one of the most effective cancer prevention measures and calls on Member States to ensure that all women and girls have access to such screening;
Amendment 223 #
Motion for a resolution
Paragraph 9
Paragraph 9
Amendment 239 #
Motion for a resolution
Paragraph 11
Paragraph 11
11. Is disappointed by the fact that the annual budgets for programmes designed to prevent male violence against women in all Member States is much less than the actual cost of such violence, be it in economic, psychological, social or moral in nature;
Amendment 290 #
Motion for a resolution
Paragraph 19
Paragraph 19
19. Asks the Commission to incentivise projects at EU level focused on how women are treatedthe proper treatment of women in clinical research; such projects should involve health authorities at all levels and the pharmaceutical industry;